TGF-β signaling during SARS-CoV-2 infection has also been associated with NK cell dysregulation that limits functional activity contributing to subsequent viral pathogenesis (194, 217), showing that TGF-β inhibitors may have rationale to be applied in acute viral infections too. The gene discussed is TGFB1; the disease is viral infectious disease.